Additional fundraising through various linked activities such as commemorative t-shirt sales and charity auctions
▲2024 Coast 2 Coast 4 Cancer site (Photo provided by BMS Pharmaceutical Korea)
BMS Pharmaceutical Korea announced on the 16th that for the first time this year, Korean employees participated in ‘Coast 2 Coast 4 Cancer (C2C4C)’, a global bicycle relay to support cancer patients, which is BMS Global’s representative social contribution activity.
C2C4C is a program in which BMS employees from around the world cross the country by bicycle to raise awareness of the importance of cancer treatment and to raise funds to support cancer patients. It started in the United States in 2014 and has now expanded to Europe, Japan, and Latin America.
This year, Manager Song Hee of the Patient Safety Team at BMS Pharmaceuticals Korea participated in C2C4C for the first time in Korea. C2C4C, in which Manager Song participated, was held in Japan, and about 60 BMS employees from each country gathered in Japan were divided into 5 teams and ran 1,800km across Japan for 2 weeks from October 1st. Among the courses that pass through Chiba, Gunma, Nagano, and Gifu, Manager Song completed the 300km section starting from Suwa City, Nagano Prefecture to Otemachi, Tokyo from October 13th to 15th. Among Asian countries, only Japan, the host country, has participated in the global relay, so this Korean employee’s first participation and completion was significant.
Manager Song Hee said, “I have been consistently training on my bike to participate in C2C4C using my spare time,” and added, “It was physically very difficult for three days, but I finished the race with the thought that our efforts would bring hope to patients. “Based on the knowledge and passion I have gained, I will focus my efforts on managing the safety of medicines for domestic patients,” he said.
BMS Pharmaceutical Korea carried out various domestic activities to celebrate and support Korean employees’ first participation in C2C4C. An additional donation of approximately 3 million won was raised from the proceeds from the sale of T-shirts commemorating C2C4C. In addition, from ‘Global Patient Week’, the last week of September, to mid-October, when C2C4C concludes, we are running the ‘Move for Patients’ certification campaign to show support by walking or riding a bicycle with family, friends, and colleagues. reported. In addition, all proceeds from a charity auction held through voluntary item donations by employees were donated as additional donations.
All donations raised through C2C4C and related events, along with the amount raised during World Patient Week, including ‘Steps for Patients’ last September, will be donated to the Milal Welfare Foundation. This will be used for ‘Reboot‘, a self-reliance support program for low-income young cancer patients, and ‘Recover‘, a program to improve the treatment environment for cancer patients, which are BMS Pharmaceutical Korea’s representative social contribution activities. This year, through additional fundraising activities to commemorate the 10th anniversary of World Patient Week and to support Korean employees’ first C2C4C participation, more donations were made and more patients were supported than in previous years.
Lee Hye-young, CEO of BMS Pharmaceutical Korea, said, “BMS Pharmaceutical Korea is striving to improve the quality of life of patients and their guardians through comprehensive social contribution activities starting from World Patient Week in September, C2C4C, and Patient Guardian Day scheduled for December. Going forward, we will not only quickly supply innovative treatments for patients with severe and rare diseases, but we will also continue to discover and implement support measures that can bring real changes to the daily lives of patients and their guardians.”
